Home » Topics » Regulatory » EMA

EMA
RSS

LMS-611 obtains European orphan drug status in cystic fibrosis

June 21, 2011

French and German authorities suspend use of pioglitazone-containing products

June 14, 2011

COMP issues opinion on orphan drug of CYT-387 in myelofibrosis

June 2, 2011

EMA to review Gentium's MAA for defibrotide under accelerated assessment

June 2, 2011

EMA accepts Pfizer's regulatory filing for axitinib in renal cell carcinoma

June 2, 2011

EMA and Health Canada recommend revaccination with Ixiaro vaccine due to batch recall

May 30, 2011

EMA accepts for review Savient Pharmaceuticals' MAA for Krystexxa

May 30, 2011

NeuroSearch to conduct phase III confirmatory trial of Huntexil

May 26, 2011

CHMP issues negative trend vote on Bronchitol for cystic fibrosis

May 25, 2011

EMA's CHMP recommends label extension for tocilizumab

May 24, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...